H1N1 injectable vaccines and nasal spray vaccines were made available to all students at Fairfield University free of charge on Friday, as outlined in a university message, almost two weeks after other universities received vaccine supplies.
The university message sent out to all students on Friday stated that “healthy individuals through age 24 years old” could receive the LAIV nasal spray vaccine, while individuals “64 years old or less with underlying medical conditions” could receive the injectable vaccine.
Vaccine Availability Varies
The initial limited availability of vaccines became even more frustrating for many students when they heard about other universities making the vaccine more widely available.
Fairfield University, which “was approved to receive and distribute H1N1 vaccine to members of the University community who fall within the approved target populations,” according to the university message, was more than two weeks behind other Connecticut schools not only in vaccine distribution, but even in communicating the imminent availability of the vaccines.
No information was provided to students or other University community members explaining when the vaccines would be made available. Health Center administrators did not respond to three calls and an e-mail made asking for information.
Last week, Loyola University in New Orleans held a series of clinics that offered free H1N1 vaccines to all students. Fordham University is holding clinics this week offering both H1N1 and season flu vaccines to its students as well. Loyola College in Maryland has made the H1N1 vaccine more readily available, according to Jennifer Monahan, a sophomore enrolled in the college.
“Last Monday and Tuesday, they offered the vaccine to any student from 18 to 24, with a student ID,” Monahan said. Loyola College is also taking some severe steps in order to prevent the spread of swine flu.
“There are certain apartment-style dorms reserved strictly for the people who have swine, and live too far away to go home,” Monahan said. The Health Center also instated a rule where face masks were to be worn at all times.
Even other colleges in the state of Connecticut had H1N1 vaccine clinics for their students before Fairfield. UConn announced that any healthy student age 24 and younger, in addition to the higher-priority groups, will be eligible to register for a vaccine. The University of Hartford also held two clinics recently, providing vaccines to 750 students and promising to hold more clinics once they receive more vaccines. Yale University offered vaccines to healthy students between the ages of 18-24 through clinics requiring registration, in order to account for all vaccines distributed.
Fairfield student Chelsea Pabon ’12 was frustrated by the lack of vaccines on campus. “They definitely should [have more vaccines available], especially on campus; people are dropping like flies, and it’s affecting their schoolwork,” she said. “I walk around with my own [hand sanitizer] now, the sprayer [sanitzer dispensers] are always empty.”
Delayed Reaction
This recent supply is the second that Fairfield has received since the first release of the vaccines. The first supply of H1N1 vaccines arrived in the Fairfield University Health Center a few weeks ago, but with very strict distribution guidelines making the vaccines unavailable to the majority of students and faculty.
“Everyone should be able to be immunized. If someone’s really scared [about contracting the flu], they should be able to, not be restricted by campus,” said student Jessica Soyer ’13.
Despite the three reported cases of swine flu and the 60 cases of flu-like symptoms so far, Fairfield University was initially very selective in its distribution of the vaccine. As outlined in a preliminary university message sent to all students and faculty, the health center was issuing vaccines only to individuals with serious medical conditions.
Students and faculty who were in good health, without underlying conditions, “are NOT eligible to be vaccinated with this initial limited supply,” the preliminary message outlined. Some of the qualifying health conditions included asthma, diabetes, blood disorders, and weakened immune systems.
Students Debate Usefulness of Vaccine
Though vaccines are now available at Fairfield, not all students will be lining up to be vaccinated.
“I feel like they shouldn’t [vaccinate students] – half the time vaccines don’t even work,” said Daniel Malone ’13. “All this rush increases the scare for people. Getting vaccinated isn’t really worth it.”
Freshman Peter Lyons agrees that the vaccines are not the best solution to the growing problem.
“I think people should not get the vaccine. People have a better chance of getting the virus when you bring it into contact with them.”
“I don’t want the vaccine,” said Sam Goodnow ’13. “I take other precautions.”
Such precautions, such as rigorous hand-washing, use of hand sanitizers, and covering your mouth when you cough, are all important “proactive steps to minimize exposure to the flu and other illnesses,” the health center message noted.
Some students question the safety of the vaccine. Because the vaccine was produced so quickly to meet national demands, many worry that it has not been through the same precautionary examinations as the regular seasonal flu vaccine or others like it. As Carolina Arias ’12 noted, she will not be getting a vaccine because, “It hasn’t been tested enough to know the long term effects.”
Vaccine Safety Reinforced
Yet despite such fears, the Centers for Disease Control maintain that the vaccine is just as safe as a regular seasonal flu vaccine. Their website explains, “We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have a very good safety track record.” The vaccines have been tested and are expected to be pivotal in helping to prevent H1N1 flu from being an even greater concern.
The site goes on to say that even though fears and possible side effects do exist, “Vaccination is the best way to prevent influenza infection and its complications.”